Loading...
Images of Shundong Cang
(0 from 0 )Business Profiles
Books & Literature
authors:"Shundong Cang" - Search | Paperity
paperity.org
Paperity: the 1st multidisciplinary aggregator of Open Access journals & papers. Free fulltext PDF articles from hundreds of disciplines, all in one place
Music
Full text of "Synergistic effect of paclitaxel and epigenetic agent...
archive.org
... cell cycle arrest and apoptosis in breast cancer cells Katherine Liu 1t , Shundong Cang 2t , Yuehua Ma 2 and Jen Wei Chiao 1 * Abstract: This study examined ...
Related Documents
CiteSeerX — Background
citeseerx.ist.psu.edu
BibTeX @MISC{Cang_background, author = {Shundong Cang and Nikhil Mukhi and Kemeng Wang and Delong Liu}, title = {Background}, year = {}}
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical ...
www.scienceopen.com
Authors: Shundong Cang , Chaitanya Iragavarapu , John Savooji , Yongping Song , Delong Liu. Publication date (Electronic): 20 November ...
CiteSeerX — Journal of Hematology & Oncology BioMed Central Review
citeseerx.ist.psu.edu
BibTeX @MISC{Cang09journalof, author = {Shundong Cang and Yuehua Ma and Delong Liu}, title = {Journal of Hematology & Oncology BioMed Central Review}, year = …
Novel CD20 monoclonal antibodies for lymphoma therapy – ScienceOpen
www.scienceopen.com
Novel CD20 monoclonal antibodies for lymphoma therapy. Authors: Shundong Cang 1, Nikhil Mukhi 2, Kemeng Wang 2, Delong Liu 2. Publication date ...
Scientific Publications
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development |...
jhoonline.biomedcentral.com
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development Shundong Cang and Chaitanya Iragavarapu contributed equally to this work. Declarations
Shundong Cang – ScienceOpen
www.scienceopen.com
ScienceOpen: research and publishing network. To top. Advanced Search
Experimental Hematology & Oncology | Editorial board
ehoonline.biomedcentral.com
Experimental Hematology & Oncology publishes preclinical, basic, patient-oriented and translational research in all areas of hematology and oncology. The...
Phenethyl isothiocyanate and paclitaxel synergistically enhanced...
ehoonline.biomedcentral.com
Phenethyl isothiocyanate and paclitaxel synergistically enhanced apoptosis and alpha-tubulin hyperacetylation in breast cancer cells. Shundong Cang ...
Publications
Publications Authored by Shundong Cang | PubFacts
www.pubfacts.com
Publications Authored by Shundong Cang
Phenethyl isothiocyanate and paclitaxel synergistically enhanced...
link.springer.com
Shundong Cang Affiliated with Department of Oncology, Henan Province People’s Hospital, Zhengzhou University , Yuehua Ma Affiliated with Department of Oncology ...
jhoonline.org - BioMedSearch
www.biomedsearch.com
4. Jiahuai Tan, Shundong Cang, Yuehua Ma, Petrillo LRichard, Delong Liu: Novel histone deacetylase inhibitors in clinical trials as anti-cancer.
Shundong Cang's Research | CureHunter
www.curehunter.com
Shundong Cang Research Topics. Disease Neoplasms (Cancer) Cutaneous T-Cell Lymphoma (Lymphoma, T Cell
Reports & Statements
CrossRef Cited By Search Results : nature.com
www.nature.com
Nature - the world's best science and medicine on your desktop
ABT-199 (venetoclax)和BCL-2抑制剂在临床开发中- 汤教授新药信息和 ...
www.blogbus.com
ABT-199 (venetoclax) and BCL-2 inhibitor in clinical development. Shundong Cang,# Chaitanya Iragavarapu,# John Savooji，Yongping Song, ...
Miscellaneous
WO A1 - A method for predicting the responsiveness a patient...
patents.google.com
3, *, SHUNDONG CANG ET AL: "Novel CD20 monoclonal antibodies for lymphoma therapy", JOURNAL OF HEMATOLOGY & ONCOLOGY, ...
(PDF) Novel CD20 monoclonal antibodies for lymphoma therapy | Nikhil...
www.academia.edu
Shundong Cang. Delong Liu. Cang et al. Journal of Hematology & Oncology 2012, 5:64 http://www.jhoonline.org/content JOURNAL OF HEMATOLOGY ...
"Hypoacetylation, Hypomethylation, and Dephosphorylation of H2B...
touroscholar.touro.edu
Shundong Cang Xiaobin Xu Yuehua Ma Delong Liu, New York Medical College J.W. Chiao, New York Medical College. Document Type. Article. Publication Date
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical Scite.ai
scite.ai
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. Shundong Cang, Chaitanya Iragavarapu, John Savooji, Yongping Song, Delong Liu.
Báo cáo y học: "nomic mapping of RNA polymerase II reveals sites of -...
123docz.net
Jiahuai Tan, Shundong Cang, Yuehua Ma, Petrillo LRichard, Delong Liu:Novel histone deacetylase inhibitors in clinical ... College Tianjin China.2West China ...
Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous...
www.pagepress.org
Shundong Cang. Division of Hematology and Oncology, New York Medical College, Valhalla, NY , United States. Ting Yang. Department ...
Drug interactions with the tyrosine kinase inhibitors imatinib,...
ashpublications.org
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, ... Shundong Cang, ... kinase inhibitors imatinib, dasatinib, and nilotinib.
Altmetric – Novel histone deacetylase inhibitors in clinical trials...
www.altmetric.com
Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo, Delong Liu. Abstract. Histone deacetylases (HDACs) can regulate expression of tumor suppressor ...
Altmetric – Third-generation inhibitors targeting EGFR T790M mutation...
www.altmetric.com
Shuhang Wang, Shuhang Wang, Shundong Cang, Delong Liu. Abstract. The tyrosine kinase inhibitors (TKI) against epidermal growth factor ...
Novel histone deacetylase inhibitors in clinical trials as...
www.semanticscholar.org
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo, Delong Liu;
Metastatic lung cancer associated with Warthin's tumour ...www.njcponline.com › article
www.njcponline.com
Fengxia Chen,Hongmei Zhang,Ling Jiang,Wei Wei,Chunchun Liu,Shundong Cang. Journal of Photochemistry and Photobiology B: Biology.
New clinical developments in histone deacetylase inhibitors ...search.ebscohost.com › login
web.s.ebscohost.com
Email: Shundong Cang - ; Yuehua Ma - .cn; Delong Liu* - .
Novel ALK inhibitors in clinical use and development - Altmetric
www.altmetric.com
Chaitanya Iragavarapu, Milaim Mustafa, Akintunde Akinleye, Muhammad Furqan, Varun Mittal, Shundong Cang, Delong Liu. Abstract. Anaplastic lymphoma ...
Novel agents for advanced pancreatic cancer - Oncotargetwww.oncotarget.com › ...
www.oncotarget.com
Oncotarget | https://doi.org oncotarget Akintunde Akinleye, Chaitanya Iragavarapu, Muhammad Furqan, Shundong Cang, ...
Deficient histone acetylation and excessive deacetylase activity as...
www.spandidos-publications.com
Authors: Shundong Cang, Jingyang Feng, Sensuke Konno, Liying Han, Katherine Liu, Sansar C. Sharma, Muhammad Choudhury, J. W. Chiao.
Novel ALK inhibitors in clinical use and development - Semantic...
www.semanticscholar.org
Novel ALK inhibitors in clinical use and development. Chaitanya Iragavarapu, Milaim Mustafa, Akintunde Akinleye, Muhammad Furqan, Varun Mittal, Shundong Cang, …
Papers with the keyword Cytotoxic (Page 11) | Read by QxMD
read.qxmd.com
Fengxia Chen, Hongmei Zhang, Ling Jiang, Wei Wei, Chunchun Liu, Shundong Cang. In recent years, biological nanomedicine-based biomaterials have an ...
Hypoacetylation, hypomethylation, and dephosphorylation of H2B...
www.infona.pl
Shundong Cang. The People's Hospital of Henan Province, Department of Oncology, Zhengzhou, China... Xiaobin Xu. Boston University School of Medicine, ...
Third-generation inhibitors targeting EGFR T790M mutation in advanced...
read.qxmd.com
Shuhang Wang, Shundong Cang, Delong Liu. Journal of Hematology & Oncology 2016, 9:
DataCite Search
search.datacite.org
Shundong Cang, Xiaobin Xu, Yuehua Ma, Delong Liu & J. Chiao. Collection published via Figshare. Abstract Background Hypoacetylation on histone H3 ...
Related search requests for Shundong Cang
| Varun Mittal Nikhil Mukhi Publication Date |
People Forename "Shundong" (3) Name "Cang" (113) |
sorted by relevance / date